Home Business Opportunities Licensing New Products/Technologies New Leads
Hormone replacement therapy/antiosteoporetic/antibreast cancer
 

.

1 Potent molecules with estrogen antagonistic activity.
2 Useful in fertility regulation.
3 Useful in osteoporosis, breast cancer, estrogen replacement therapy hypercholesteremia, endometriosis, vasoconstriction, endometrial disorder and in CVS and CNS disorders.
-
.

IPR covered:
Country Details
1. US

Application pending filed on March 28, 2000

2. European

Application pending filed on March 30, 2000

3. Japanese

Application pending filed on March 30,2000
4. Indian

Application no 230/DEL/1998 dated 28/01/1998
5. India

Application no 231/DEL/1998 dated 28/01/1998

6. India

Application no 232/DEL/1998 dated 28/01/1998

7. India

Application no 233/DEL/1998 dated 28/01/1998
8. India

Application no 234/DEL/1998 dated 28/01/1998

9. India

Application no 235/DEL/1998 dated 28/01/1998

10. India

Application no 236/DEL/1998 dated 28/01/1998

11. India

Application no 237/DEL/1998 dated 28/01/1998

-
-

The Organisation | Programme & Activities | Expertise Available | Achievements | Business Opportunities
| Career Opportunities
.